Back
Southern Vs. Novo Nordisk AS Industry Stock Comparison
Buy
55
SO
Southern
Last Price:
$83.02
Seasonality Move:
-0.6%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$85.04
Seasonality Move:
9.09%
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.04. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
SO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.14 | Sell |
Relative Strength Index (14 RSI): | 46.62 | Sell |
Chaikin Money Flow: | 7364947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.75 - 84.59) | Sell |
Bollinger Bands (100): | (84.49 - 90.67) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.19 | Sell |
Relative Strength Index (14 RSI): | 32.42 | Sell |
Chaikin Money Flow: | -1041 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.31 - 109.25) | Sell |
Bollinger Bands (100): | (99.35 - 129.37) | Sell |
SO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.16 | Buy |
20-day SMA: | 82.59 | Buy |
50-day SMA: | 85.85 | Sell |
200-day SMA: | 82.62 | Buy |
8-day EMA: | 82.18 | Buy |
20-day EMA: | 83.03 | Sell |
50-day EMA: | 85.01 | Sell |
200-day EMA: | 82.72 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.85 | Sell |
20-day SMA: | 94.98 | Sell |
50-day SMA: | 102.41 | Sell |
200-day SMA: | 123.63 | Sell |
8-day EMA: | 86.44 | Sell |
20-day EMA: | 92.43 | Sell |
50-day EMA: | 101.51 | Sell |
200-day EMA: | 114.69 | Sell |
Southern Earnings Growth & SO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.28 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Southern Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |